MD, MSc
Assistant Professor, Medicine-Hematology
UNC-Chapel Hill
Cancer Prevention and Control
Area of Interest
The goal of my research career is to improve the quality of care and outcomes of patients with cancer by developing interventions to better align care delivery with what matters most to patients. I believe it is a fundamental obligation—a first principle of caring for patients—to make treatment decisions that aim to achieve the outcomes that patients most value.
My previous background and training in hematology/oncology, philosophy and ethics, and clinical research provides an exceptional foundation for advancing patient-centered care. My previous work has demonstrated how stated preference methods, such as discrete choice experiments and best-worst scaling surveys, can quantify patients’ preferences for treatment outcomes and could be useful at informing patient-centered shared decision-making for chemotherapy.
I am currently working to develop interventions using these methods to inform shared decision making regarding chemotherapy and align cancer care delivery more broadly to individual patient preferences in real-time. Although my primary focus currently is on patients with acute myeloid leukemia (AML), I plan to expand the use of these methods across cancer care including clinical trials and the capture of patient-reported outcomes.
Awards and Honors
- New Investigator Program Award , The Cancer Information & Population Health Resource, 2020-2021
- Young Investigator Award, ASCO Conquer Cancer, 2020-2021
- Outstanding Fellow Award, North Carolina Oncology Association, 2019
- Abstract Merit Award: “Development of an ‘Art of Oncology’ curriculum to mitigate burnout and foster solidarity among hematology/oncology fellows”, ASCO Conquer Cancer, 2019
- CRTI Participant, American Society of Hematology, 2019-2020
- Grand Prize Poster Competition, UNC Wellness Expo, 2019
- Abstract Achievement Award: “Patients with AML Worry about More Than Just Dying: Quantifying Patient Experience Using Best-Worst Scaling”, American Society of Hematology, 2018
- Chairman’s Award for Scholarly Achievement , Ohio State University Internal Medicine Residency, 2017
- Outstanding Poster Presentation, Travel Award: “Relapsed Acute Lymphoblastic Leukemia presenting as Infiltrative Cardiomyopathy: A case presentation and review of the literature”, OSU Trainee Research Day, 2016
- First Place in Poster Competition, Travel Award: “Psychosocial Vulnerability Is Associated with Higher Hospital Readmission Rates for Hematopoietic Stem Cell Transplant Patients”, American College of Physicians, Ohio Chapter, 2016
- Abstract Achievement Award: “Psychosocial Risk Is Associated with High Readmission Rates and Increased Length of Stay for Patients following Hematopoietic Stem Cell Transplantation”, American Society of Hematology, 2016
News and Stories
UNC researchers present latest findings at American Society of Hematology Annual Meeting
Researchers from UNC Lineberger and UNC will present findings from studies, speak at scientific symposia and lead educational sessions at the 65th American Society of Hematology Annual Meeting.
UNC Lineberger research featured at American Society of Clinical Oncology annual meeting
UNC Lineberger members and trainees will present cancer research findings at the 2023 American Society of Clinical Oncology annual meeting in Chicago, June 2-6.
Accurate assessment of heart rhythm can optimize chemotherapy use
Using the wrong mathematical formula to assess heartbeat rhythms may lead oncologists to inappropriately stop life-saving chemotherapy, according to research findings from UNC Lineberger scientists.
UNC Lineberger faculty present research at the American Society of Clinical Oncology annual meeting
UNC Lineberger members will be presenting research findings, providing commentary and leading education sessions at the American Society of Clinical Oncology’s 58th annual meeting.
